WebMar 25, 2024 · Gilead Sciences, Inc. (NASDAQ:GILD - Get Rating) - Zacks Research lifted their Q1 2024 earnings estimates for Gilead Sciences in a research note issued to investors on Wednesday, March 22nd. ... The firm has a market cap of $98.22 billion, a price-to-earnings ratio of 21.58, a PEG ratio of 0.94 and a beta of 0.38. Institutional Investors … WebSep 22, 2024 · Gilead Sciences is a biotechnology company headquartered in Foster City, California, founded in 1987. Currently, the company's market cap is $82.05 Billion. The company has an EPS of $3.27 on a ...
Wakefield Asset Management LLLP Grows Stock Position in Gilead …
WebFeb 12, 2024 · If Gilead has bad news on magrolimab, it could ripple throughout the industry. ... Market Cap. $103B. Today's Change (0.32%) $0.27. Current Price. $82.86. WebApr 6, 2024 · GILD: Get the latest Gilead Sciences stock price and detailed information including GILD news, historical charts and realtime prices. ... Market Cap. 1.25 B Number of Shares. 82.45 Day Low. 83.09 ... brake conversion drum to disc
Signaturefd LLC Purchases 2,441 Shares of Gilead Sciences, Inc.
WebApr 11, 2024 · How do Gilead Sciences's earnings and revenue compare to its market cap? GILD fundamental statistics; Market Cap: US$103.15b: Earnings (TTM) US$4.59b: Revenue (TTM) US$27.28b: 22.4x P/E Ratio. 3.8x P/S Ratio. Is GILD overvalued? See Fair Value and valuation analysis. Earnings & Revenue. WebMar 13, 2024 · As of the previous market close, Gilead Sciences, Inc. has a market cap of $99.14B, which represents its share price of $79.50 multiplied by its outstanding shares … WebApr 11, 2024 · How much is Gilead Sciences stock worth today? ( NASDAQ: GILD) Gilead Sciences currently has 1,247,105,154 outstanding shares. With Gilead Sciences stock … haewr-1890